Search Within

Armaan Haseeb Siddiquee

Formats
  1. Meeting Abstract (6)
  2. Journal Article (5)
Groups
  1. Pediatrics, Department of (11)
  2. Sarcoma Service (Pediatrics) (11)
  3. Center for Hematologic Malignancies (10)
  4. Executive Committee, Center for Hematologic Malignancies (10)
  5. Stem Cell Transplantation and Cellular Therapy Service (10)
  6. Tow Center for Developmental Oncology (TCDO) (10)

More Groups

People
  1. Filemon Dela Cruz (11)
  2. Andrew Kung (10)
  3. Daoqi You (9)
  4. Diego Ferreira Coutinho (7)
  5. Michael Ortiz (7)
  6. Glorymar Ibanez Sanchez (6)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2022 (6)
  4. 2021 (1)
  5. 2020 (2)
Publications
  1. Cancer Research (2)
  2. Journal of Clinical Oncology (2)
  3. Blood (1)
  4. Cancer Discovery (1)
  5. European Journal of Cancer (1)
  6. Med (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (2)
  3. Amer Assoc Advancement Science (1)
  4. American Society of Hematology (1)
  5. Cell Press (1)
  6. Elsevier Inc. (1)

More Publishers

Results (11)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Evaluating antitumor activity and response determinants to trastuzumab deruxtecan in pediatric solid tumors
    Meeting Abstract

    Burke, C.; Ferreira Ferreira Coutinho, D.; Ibanez, G.; You, D.; Ndengu, A. A.; Calder, P.; Guillan, K.; Siddiquee, A.; Rosales, N.; Long, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • A transcripto me-based precision oncology platform for patient-therapy alignment in a diverse set of treatment-resistant malignancies
    Journal Article

    Mundi, P. S.; Dela Cruz, F. S.; Grunn, A.; Diolaiti, D.; Mauguen, A.; Rainey, A. R.; Guillan, K.; Siddiquee, A.; You, D.; Realubit, R.; more...
    Cancer Discovery (2023)

    Fulltext@MSK | Save
  • Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine
    Meeting Abstract

    Dela Cruz, F. S.; McCarter, J. G.; You, D.; Bouvier, N.; Wang, X.; Guillan, K. C.; Siddiquee, A. H.; Souto, K. B.; Li, H.; Gao, T.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Targeting of the nuclear export protein XPO1 represents a non-genetically encoded vulnerability in malignant rhabdoid and Wilms tumors
    Meeting Abstract

    Coutinho, D. F.; Burke, C.; Mundi, P.; Ortiz, M. V.; Vallance, K. L.; Long, M.; Rosales, N.; Ibanez, G.; Marks, L. J.; Diolaiti, D.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Effects of LSD1 inhibition with Img-7289 on the leukemia initiating cell population with induction of differentiation and cell death in pediatric relapsed/refractory AML
    Meeting Abstract

    Rosenzweig, J.; Coutinho, D. F.; Long, M.; Souto, K.; Sanchez, G. I.; Fishkin, R.; Guillan, K.; Siddiquee, A.; Calder, P.; You, D.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Validation of a non-oncogene encoded vulnerability to exportin 1 inhibition in pediatric renal tumors
    Journal Article

    Coutinho, D. F.; Mundi, P. S.; Marks, L. J.; Burke, C.; Ortiz, M. V.; Diolaiti, D.; Bird, L.; Vallance, K. L.; Ibáñez, G.; You, D.; more...
    Med (2022)

    Fulltext@MSK | Save
  • RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition
    Journal Article

    Nunes, C.; Depestel, L.; Mus, L.; Keller, K. M.; Delhaye, L.; Louwagie, A.; Rishfi, M.; Whale, A.; Kara, N.; Andrews, S. R.; more...
    Science Advances (2022)

    Fulltext@MSK | Save
  • Bromodomain 4 inhibition leads to MYCN downregulation in Wilms tumor
    Journal Article

    Woods, A. D.; Berlow, N. E.; Ortiz, M. V.; Dela Cruz, F.; Siddiquee, A.; Coutinho, D. F.; Purohit, R.; Tranbarger Freier, K. E.; Michalek, J. E.; Lathara, M.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Translational strategies for repotrectinib in neuroblastoma
    Journal Article

    O'Donohue, T. J.; Ibáñez, G.; Coutinho, D. F.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; You, D.; Long, M.; more...
    Molecular Cancer Therapeutics (2021)

    Fulltext@MSK | Save
  • TPX-0005 (Repotrectinib), a next-generation ALK/ROS1/NTRK1-3 inhibitor, has potent antiproliferative and anti-tumor activity as monotherapy and in combination with chemotherapy in neuroblastoma cell lines and pediatric patient derived xenograft models
    Meeting Abstract

    O'Donohue, T.; Ibáñez, G.; Mauguen, A.; Siddiquee, A.; Rosales, N.; Calder, P.; Ndengu, A.; Roberts, S.; Dela Cruz, F.; Kung, A.
    European Journal of Cancer (2020)

    Fulltext@MSK | Save